The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Preclinical development of a microRNA-based therapy for intervertebral disc degeneration
Open accessAbstract
Understanding the molecular mechanisms regulating the maintenance and destruction of intervertebral disc may lead to the development of new therapies for intervertebral disc degeneration (IDD). Here we present evidence from miRNA microarray analyses of clinical data sets along with in vitro and in vivo experiments that miR-141 is a key regulator of IDD. Gain- and loss-of-function studies show that miR-141 drives IDD by inducing nucleus pulposus (NP) apoptosis. Furthermore, miR-141 KO in mice attenuated spontaneous and surgically induced IDD. Mechanistically, miR-141 promotes IDD development by targeting and depleting SIRT1, a negative regulator of NF-κB pathway. Therapeutically, upregulation or downregulation of miR-141 by nanoparticle delivery in IDD model aggravated or alleviated experimental IDD, respectively. Our findings reveal a novel mechanism by which miR-141, in part, promotes IDD progression by interacting with SIRT1/NF-κB pathway. Blockade of miR-141 in vivo may serve as a potential therapeutic approach in the treatment of IDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationMicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
Cited by
Zhang, W., Li, G., Luo, R., Lei, J., Song, Y., Wang, B., Ma, L., Liao, Z., Ke, W., Liu, H., et al. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00729-9 · Cited by 325
Self-citationNF‐κB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration
Zhang, G., Liu, M., Chen, H., Wu, Z., Gao, Y., Ma, Z., He, X., & Kang, X. (2021) · Cell Proliferation · doi:10.1111/cpr.13057 · Cited by 261
ATF1 and miR-27b-3p drive intervertebral disc degeneration through the PPARG/NF-κB signaling axis
Guo, W., Mu, K., Geng, J.-C., Xing, H.-Y., Dong, Y., Liu, W.-D., Wang, S.-C., Shi, J.-X., Xing, B.-R., Zhao, J.-Y., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08186-6 · Cited by 7
Metadata
- Authors
- Ji, M.-L., Jiang, H., Zhang, X.-J., Shi, P.-L., Li, C., Wu, H., Wu, X.-T., Wang, Y.-T., Wang, C., & Lu, J.
- Venue
- Nature Communications
- Published
- 2018-11-28
- Volume
- 9
- Issue
- 1
- Pages
- 5051-5051
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2901270382
- Cited by
- 259
- References
- 4
- FWCI
- 13.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preclinical development of a microRNA-based therapy for intervertebral disc degeneration. https://app.cochat.ai/papers/10.1038/s41467-018-07360-1
- The paper
- Ji, M.-L., Jiang, H., Zhang, X.-J., Shi, P.-L., Li, C., Wu, H., Wu, X.-T., Wang, Y.-T., Wang, C., & Lu, J. (2018). Preclinical development of a microRNA-based therapy for intervertebral disc degeneration. Nature Communications. https://doi.org/10.1038/s41467-018-07360-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.